PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 65 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,185 | -39.6% | 131 | 0.0% | 0.00% | -50.0% |
Q2 2023 | $3,618 | +20.1% | 131 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $3,013 | -20.0% | 131 | -62.0% | 0.00% | 0.0% |
Q4 2022 | $3,764 | +25.5% | 345 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $3,000 | 0.0% | 345 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $3,000 | -66.7% | 345 | +38.0% | 0.00% | -60.0% |
Q4 2021 | $9,000 | +125.0% | 250 | 0.0% | 0.01% | +150.0% |
Q3 2021 | $4,000 | -63.6% | 250 | 0.0% | 0.00% | -66.7% |
Q2 2021 | $11,000 | +83.3% | 250 | 0.0% | 0.01% | +100.0% |
Q1 2021 | $6,000 | +200.0% | 250 | +110.1% | 0.00% | +200.0% |
Q4 2020 | $2,000 | 0.0% | 119 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $2,000 | +100.0% | 119 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $1,000 | 0.0% | 119 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,000 | 0.0% | 119 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $1,000 | -66.7% | 119 | -52.8% | 0.00% | 0.0% |
Q3 2018 | $3,000 | – | 252 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |